Metabolix, Inc. Stock Nasdaq
Equities
US5910188094
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 2.25M | Sales 2025 * | 4M | Capitalization | 3.68M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | -13M | EV / Sales 2024 * | 1.64 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.92 x |
P/E ratio 2024 * |
-0.32
x | P/E ratio 2025 * |
-0.28
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on Metabolix, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Oliver Peoples
FOU | Founder | 66 | 92-05-31 |
Charles Haaser
DFI | Director of Finance/CFO | 68 | 07-12-31 |
Kristi Snell
CTO | Chief Tech/Sci/R&D Officer | 56 | 96-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 06-09-30 | |
Richard Hamilton
BRD | Director/Board Member | 61 | 17-03-01 |
Oliver Peoples
FOU | Founder | 66 | 92-05-31 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |